These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26174892)

  • 21. Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients.
    Kahwaji J; Barker E; Pepkowitz S; Klapper E; Villicana R; Peng A; Chang R; Jordan SC; Vo AA
    Clin J Am Soc Nephrol; 2009 Dec; 4(12):1993-7. PubMed ID: 19833910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of hemolysis with high dose intravenous immunoglobulin therapy in pediatric patients: An open-label prospective trial.
    Akman AO; Kara FK; Koksal T; Cakir BC; Karagol C; Sayli T
    Transfus Apher Sci; 2017 Aug; 56(4):531-534. PubMed ID: 28818402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes.
    Michelis FV; Branch DR; Scovell I; Bloch E; Pendergrast J; Lipton JH; Cserti-Gazdewich CM
    Transfusion; 2014 Mar; 54(3):681-90. PubMed ID: 23829192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemolysis upon intravenous immunoglobulin transfusion.
    Padmore RF
    Transfus Apher Sci; 2012 Feb; 46(1):93-6. PubMed ID: 22169381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic plasma exchange as a therapeutic modality for the treatment of IVIG complications.
    Welsh KJ; Bai Y
    J Clin Apher; 2015 Dec; 30(6):371-4. PubMed ID: 26123478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-red blood cell antibodies, free light chains, and antiphospholipid antibodies in intravenous immunoglobulin preparations.
    Sakem B; Matozan K; Nydegger UE; Weigel G; Griesmacher A; Risch L
    Isr Med Assoc J; 2013 Oct; 15(10):617-21. PubMed ID: 24266088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders.
    Markvardsen LH; Christiansen I; Harbo T; Jakobsen J
    Eur J Neurol; 2014; 21(1):147-52. PubMed ID: 24180709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-A and anti-B hemagglutinin depletion during Cohn purification process of 5% immunoglobulin.
    Salvatore A; Esin S; Batoni G; Ascione E; Farina C; Nardini C
    Transfusion; 2015 Jul; 55 Suppl 2():S110-6. PubMed ID: 26174888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immunoglobulin-related hemolysis in patients treated for Kawasaki disease.
    Luban NL; Wong EC; Henrich Lobo R; Pary P; Duke S
    Transfusion; 2015 Jul; 55 Suppl 2():S90-4. PubMed ID: 26174904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous immune globulin-related hemolysis: comparing two different methods for case assessment.
    Taylor E; Vu D; Legare C; Keene D
    Transfusion; 2015 Jul; 55 Suppl 2():S23-7. PubMed ID: 26174894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis and mechanisms of antibody-mediated hemolysis.
    Flegel WA
    Transfusion; 2015 Jul; 55 Suppl 2(0):S47-58. PubMed ID: 26174897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis.
    Daw Z; Padmore R; Neurath D; Cober N; Tokessy M; Desjardins D; Olberg B; Tinmouth A; Giulivi A
    Transfusion; 2008 Aug; 48(8):1598-601. PubMed ID: 18466176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Massive intravascular haemolysis after high dose intravenous immunoglobulin therapy.
    Mohamed M; Bates G; Eastley B
    Br J Haematol; 2013 Mar; 160(5):570. PubMed ID: 23294261
    [No Abstract]   [Full Text] [Related]  

  • 34. Possible mechanisms for intravenous immunoglobulin-associated hemolysis: clues obtained from review of clinical case reports.
    Padmore R
    Transfusion; 2015 Jul; 55 Suppl 2():S59-64. PubMed ID: 26174898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential approaches to prevent uncommon hemolytic side effects of AB0 antibodies in plasma derivatives.
    Buchta C; Macher M; Höcker P
    Biologicals; 2005 Mar; 33(1):41-8. PubMed ID: 15713555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection and side effects of isoantibodies in intravenously administered immunoglobulin preparations].
    Strobel E; Wüllenweber J; Peters J
    Infusionsther Transfusionsmed; 1995 Feb; 22(1):31-5. PubMed ID: 7727961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Demonstration os isoagglutinins in intravenously applicable immunoglobulin preparations].
    Strobel E; Wüllenweber J; Peters J
    Beitr Infusionsther Transfusionsmed; 1994; 32():200-2. PubMed ID: 9480087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-A and anti-B haemagglutinin levels in intravenous immunoglobulins: are they on the rise? A comparison of four different analysis methods and six products.
    Bellac CL; Polatti D; Hottiger T; Girard P; Sänger M; Gilgen M
    Biologicals; 2014 Jan; 42(1):57-64. PubMed ID: 24325871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemolysis during immunoglobulin therapy].
    Muñoz J; García A; Jordán C; Rubió A; Ferrán C; Martínez Matos JA
    Sangre (Barc); 1996 Feb; 41(1):72-3. PubMed ID: 8779043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.